Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2020 R21 RFA-CA-19-019 ISSADORE, DAVID AARON UNIVERSITY OF PENNSYLVANIA High Throughput Digital Droplet ELISA for Ultrasensitive Multiplexed Diagnostics Active
2019 R21 RFA-CA-18-002 IM, HYUNGSOON MASSACHUSETTS GENERAL HOSPITAL Nano-plasmonic technology for high-throughput single exosome analyses Active
2018 R21 RFA-CA-17-010 FU, XIAO-AN UNIVERSITY OF LOUISVILLE A microreactor chip platform for quantitative analysis of unsaturated aldehydes in exhaled breath Active
2017 R21 RFA-CA-16-001 BROCK, AMY UNIVERSITY OF TEXAS, AUSTIN High resolution cell lineage tracking and isolation Active
2020 R33 RFA-CA-19-020 WEI, CHIA-LIN JACKSON LABORATORY Advancing Ultra Long-read Sequencing And Chromatin Interaction Analyses For Chromosomal And Extrachromosomal Structural Variation Characterization In Cancer Active
2020 R21 RFA-CA-19-019 CICERONE, MARCUS T GEORGIA INSTITUTE OF TECHNOLOGY Label-Free Cell-Resolved Metabolomics for Tumor Microscopy Active
2019 R21 RFA-CA-18-002 HUANG, XIAOHUA UNIVERSITY OF CALIFORNIA, SAN DIEGO Technology for measuring telomere length of individual chromosomes of single cancer cells Active
2018 R21 RFA-CA-17-010 KARGINOV, ANDREI V UNIVERSITY OF ILLINOIS AT CHICAGO Optogenetic tools for the dissection of oncogenic signaling mediated by kinases Active
2020 R44 PAR-18-303 WINTERS, IAN PAUL D2G ONCOLOGY, INC. Relating Drugs To Genotypes To Transform Precision Cancer Therapeutics With Tuba-seq - A Novel, Highly Scalable And Quantitative Preclinical Experimental Oncology Platform Active
2001 R21 PAR-99-100 GUO, BAOCHUAN CLEVELAND STATE UNIVERSITY MALDI TOF TECHNOLOGY FOR MOLECULAR ANALYSIS OF CANCER Complete
2003 R21 PAR-01-104 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INSTITUTE ERROR-FREE DNA AMPLIFICATION FOR MUTATION DETECTION Complete
2006 R33 RFA-CA-06-004 LANDERS, JAMES P UNIVERSITY OF VIRGINIA CHARLOTTESVILLE MICRODEVICE FOR DIRECT DNA PURIFICATION Complete
2009 R21 RFA-CA-08-007 LIU, YANG UNIVERSITY OF PITTSBURGH AT PITTSBURGH PARTIAL-WAVE SPECTROSCOPIC MICROSCOPY FOR THE DIAGNOSIS OF CHOLANGIOCARCINOMA Complete
2013 R21 RFA-CA-12-002 JEFFREY, STEFANIE S. STANFORD UNIVERSITY A DROPLET-BASED SYSTEM FOR CAPTURE, MANIPULATION, AND BIOCHEMICAL PROFILING OF RA Complete
2000 R33 PAR-98-067 HUANG, TIM H.-M. UNIVERSITY OF MISSOURI-COLUMBIA HIGH THROUGHPUT METHYLATION ANALYSIS IN CANCER Complete
2002 R33 PAR-99-100 CHURCHILL, GARY A JACKSON LABORATORY EXPERIMENTAL DESIGN & ANALYSIS FOR EXPRESSION MICROARRAY Complete
2005 R43 RFA-CA-05-007 PHILIP, RAMILA IMMUNOTOPE, INC. IDENTIFICATION OF AUTO ANTIGENS IN OVARIAN CANCER Complete
2008 R43 RFA-CA-07-041 KRIZMAN, DAVID BURKE EXPRESSION PATHOLOGY, INC QUANTITATIVE PROTEOMICS OF METASTASIS Complete
2011 R33 RFA-CA-10-004 GARRAWAY, LEVI A DANA-FARBER CANCER INST HIGH-THROUGHPUT TUMOR GENOMIC PROFILING BY MASSIVELY PARALLEL SEQUENCING Complete
2015 R33 RFA-CA-14-006 BROWN, JONATHAN QUINCY TULANE UNIVERSITY OF LOUISIANA IMPROVING BIOSPECIMEN QUALITY BY VERIFYING ADEQUACY AT THE POINT-OF-ACQUISITION WITH EX VIVO STRUCTURED ILLUMINATION MICROSCOPY Complete
2000 R21 PAR-98-067 GIESE, ROGER WALLACE NORTHEASTERN UNIVERSITY CATION LABELING MASS SPECTROMETRY OF DNA ADDUCTS Complete
2002 R21 PAR-01-106 BAKER, LAURENCE HOWARD UNIVERSITY OF MICHIGAN AT ANN ARBOR MOLECULAR DIAGNOSIS OF SARCOMAS Complete
2005 R21 RFA-CA-05-002 KELLEY, SHANA O BOSTON COLLEGE NANOSCALE ELECTROCATALYTIC PROTEIN DETECTION Complete
2008 R21 RFA-CA-07-033 KELLEY, SHANA O UNIVERSITY OF TORONTO DEVELOPMENT OF DNA-TEMPLATED IR QUANTUM DOTS Complete
2011 R21 RFA-CA-10-003 EVANS, CONOR LEE MASSACHUSETTS GENERAL HOSPITAL HYPERSPECTRAL AND STRUCTURAL MICROSCOPY PLATFORM FOR THERAPY OF RESISTANT CANCER Complete
2015 R21 RFA-CA-14-003 WILLIAMS, JOHN CHARLES BECKMAN RESEARCH INSTITUTE/CITY OF HOPE IN SITU IMAGING OF CAR T-CELLS Complete
1999 R21 PAR-98-067 TOLIAS, P P PUBLIC HEALTH RESEARCH INSTITUTE FUNCTIONAL CLONING OF DNA AND RNA BINDING PROTEINS Complete
2001 R33 PAR-99-102 PALLAVICINI, MARIA G. UNIVERSITY OF CALIFORNIA SAN FRANCISCO PROTEIN SIGNATURES OF LEUKEMIC CELLS Complete
2004 R21 PAR-01-106 MAITRA, ANIRBAN JOHNS HOPKINS UNIVERSITY A SEQUENCING MICROARRAY FOR MITOCHONDRIAL MUTATIONS Complete
2007 R21 RFA-CA-07-015 REICH, DANIEL H JOHNS HOPKINS UNIVERSITY MAGNETICALLY PATTERNED CO-CULTURES FOR CANCER STUDIES Complete
2010 R21 RFA-CA-09-006 TURK, BENJAMIN E YALE UNIVERSITY GLOBAL PEPTIDE MICROARRAY PROFILING OF TYROSINE KINASES DEREGULATED IN CANCER Complete
2014 R21 RFA-CA-13-001 ZAIA, JOSEPH BOSTON UNIVERSITY MEDICAL CAMPUS QUANTITATIVE PROFILING OF GLYCOSAMINOGLYCANS FROM BREAST TUMOR TISSUE ARRAYS Complete
2017 R21 RFA-CA-16-001 KESHARI, KAYVAN R. SLOAN-KETTERING INST CAN RESEARCH uCoil NMR platform for robust and high-throughput analysis of in vitro metabolic flux on living cells Complete
2001 R21 PAR-99-100 YAMAMOTO, FUMIICHIRO BURNHAM INSTITUTE FOR MEDICAL RESEARCH TECHNOLOGY TO DETECT GENOME WIDE DNA METHYLATION CHANGES Complete
2003 R21 PAR-01-104 GOODLETT, DAVID ROBINSON INSTITUTE FOR SYSTEMS BIOLOGY PARALLEL PEPTIDE TANDEM MASS SPECTROMETRY (MS) Complete
2006 R41 RFA-CA-06-006 HIRSCHOWITZ, EDWARD A 20/20 GENESYSTEMS, INC. AUTO-ANTIBODY PROFILING OF NON-SMALL CELL LUNG CANCER Complete
2009 R21 RFA-CA-08-007 YIN, HANG HUBERT UNIVERSITY OF COLORADO PROBING EBV-LMP-1'S TRANSMEMBRANE ACTIVATION DOMAIN WITH SYNTHETIC PEPTIDE ANTAGO Complete
2013 R21 RFA-CA-12-004 LAI, JAMES UNIVERSITY OF WASHINGTON BIOSPECIMEN PREPARATION TECHNOLOGIES TO ENABLE HIGH THROUGHPUT AND HIGHLY SENSITI Complete
2000 R33 PAR-98-067 GARNER, HAROLD R UNIVERSITY OF TEXAS SW MED CTR/DALLAS SOFTWARE AND INSTRUMENTATION TO IDENTIFY CANCER GENES Complete
2002 R33 PAR-99-100 FRANK-KAMENETSKII, MAXIM D BOSTON UNIVERSITY STUDIES OF HEMATOLOGIC MALIGNANCIES BY PNA TECHNOLOGY Complete
2005 R44 RFA-CA-05-006 RUSH, JOHN CELL SIGNALING TECHNOLOGY, INC. IMMUNOAFFINITY ISOLATION OF PHOSPHOPEPTIDES Complete
2008 R43 RFA-CA-07-041 CHAN, DOUG PROTECH LABORATORIES, INC. DEVELOPMENT AND APPLICATION OF TECHNOLOGY PLATFORM FOR IDENTIFICATION OF THE HIST Complete
2011 R33 RFA-CA-10-004 PORTER, MARC D UNIVERSITY OF UTAH ADVANCED DEVELOPMENT OF A MULTIPLEXED SERS-BASED BIOMARKER DETECTION PLATFORM: A Complete
2015 R43 PAR-13-327 SELIGMANN, BRUCE E. BIOSPYDER TECHNOLOGIES, INC. IN SITU RNA-FISH WITH LOCALIZED PROFILING BY SEQUENCING FROM FFPE Complete
2000 R21 PAR-98-067 CHANCE, MARK R YESHIVA UNIVERSITY DYNAMICS OF MACROMOLECULAR INTERACTIONS Complete
2002 R21 PAR-01-106 KENAN, DANIEL J. DUKE UNIVERSITY ENDOTHELIAL CELL MOLECULAR ALTERATIONS IN CANCER Complete
2005 R21 RFA-CA-05-002 PANNELL, LEWIS KENNETH UNIVERSITY OF SOUTH ALABAMA AUTOMATED GLYCO-ANALYSIS OF CANCER RELATED PROTEINS Complete
2008 R21 RFA-CA-07-033 REVZIN, ALEXANDER UNIVERSITY OF CALIFORNIA AT DAVIS MICROFABRICATION TOOLS FOR IN VITRO MONITORING OF CANCER CELL METABOLISM Complete
2011 R21 RFA-CA-10-003 LI, DEYU VANDERBILT UNIVERSITY VEC3-VALVE ENABLED CELL CO-CULTURE PLATFORMS FOR CANCER BIOLOGY STUDY Complete
2015 R21 RFA-CA-14-003 YEH, HSIN-CHIH UNIVERSITY OF TEXAS, AUSTIN AN INTEGRATED IMAGING TOOL FOR PROBING EGFR SUBCELLULAR TRAFFICKING IN REAL TIME Complete

Pages